It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Little is known on the causes and pathogenesis of the adipose tissue disorder (familial) Multiple Symmetric Lipomatosis (MSL). In a four-generation MSL-family, we performed whole exome sequencing (WES) in 3 affected individuals and 1 obligate carrier and identified Calcyphosine-like (CAPSL) as the most promising candidate gene for this family. Screening of 21 independent patients excluded CAPSL coding sequence variants as a common monogenic cause, but using immunohistochemistry we found that CAPSL was down-regulated in adipose tissue not only from the index patient but also in 10 independent sporadic MSL-patients. This suggests that CAPSL is regulated in sporadic MSL irrespective of the underlying genetic/multifactorial cause. Furthermore, we cultivated pre-adipocytes from MSL-patients and generated 3T3-L1-based Capsl knockout and overexpressing cell models showing altered autophagy, adipogenesis, lipogenesis and Sirtuin-1 (SIRT1) expression. CAPSL seems to be involved in adipocyte biology and perturbation of autophagy is a potential mechanism in the pathogenesis of MSL. Downregulation of CAPSL and upregulation of UCP1 were common features in MSL fat while the known MSL genes MFN2 and LIPE did not show consistent alterations. CAPSL immunostainings could serve as first diagnostic tools in MSL clinical care with a potential to improve time to diagnosis and healthcare options.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 University Hospital of Cologne, Institute of Human Genetics, Cologne, Germany (GRID:grid.411097.a) (ISNI:0000 0000 8852 305X)
2 University Medical Center Regensburg, Department of Dermatology, Regensburg, Germany (GRID:grid.411941.8) (ISNI:0000 0000 9194 7179)
3 University Medical Center Regensburg, Department of Plastic Surgery, Regensburg, Germany (GRID:grid.411941.8) (ISNI:0000 0000 9194 7179)
4 University of Cologne, Center for Molecular Medicine Cologne (CMMC) and Department of Internal Medicine I, Cologne, Germany (GRID:grid.6190.e) (ISNI:0000 0000 8580 3777)
5 University Hospital of Cologne, Institute of Human Genetics, Cologne, Germany (GRID:grid.411097.a) (ISNI:0000 0000 8852 305X); University of Cologne, Cologne Center for Genomics (CCG), Cologne, Germany (GRID:grid.6190.e) (ISNI:0000 0000 8580 3777)
6 University of Cologne, Cologne Center for Genomics (CCG), Cologne, Germany (GRID:grid.6190.e) (ISNI:0000 0000 8580 3777)